Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) shares dropped early on Friday after the company announced that it would be terminating its mid-stage SHERLOC study in patients with non-small cell lung cancer. Specifically, this was the Phase 2 clinical …
Lung cancer is the leading cause of cancer death among men and women worldwide, according to the American Cancer Society. Each year, more people — about 154,000 — die of lung cancer than from colon, breast, and prostate cancers combined, and the lifetime …
/arc-anglerfish-syd-prod-nzme.s3.amazonaws.com/public/TH4NZGG4DVC4LMF2IBYX4626QQ.jpg)
A Northland mother forking out $7500 every three weeks for lung cancer treatment is pleading with Pharmac to publicly fund the drugs for the killer disease and stop needless deaths. Alethea Nathan, 39, from Whangārei is undergoing chemotherapy which is …
Binding status of Nivolumab can be divided into three different types based on occupancy of PD-1 in T cells: complete binding, partial binding and no binding. PD-L1 can interact with T cells already in partial binding status. Credit: Osaka University Dr. …
The study will be done in SCLC patients in combination with Platinum-Etoposide chemotherapyMADRID, Spain and CAMBRIDGE, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), (“Oryzon”), a public clinical-stage …
Saginaw, Mich., Oct 16, 2018 / 11:37 am (CNA).- Bishop Joseph Cistone died in his home Tuesday morning, the Diocese of Saginaw has reported. Local officials told reporters they received a 911 call from the bishop’s home Tuesday morning, adding that …
Researchers from Osaka University find that a novel method for monitoring the effect of lung cancer therapy may help guide treatment choices Dr Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. …
Guardant Health Posted on: 16 Oct 18 Lung Cancer Study Published in JAMA Oncology Shows Guardant360 Outperforms Tissue Biopsy Alone in Identification of Targetable Mutations Authors and accompanying editorial conclude study supports potential utilization …
Members of the Dallas Community Join the Lung Cancer Research Foundation in the Fight Against Lung Cancer. Hundreds of Local Residents Will Hit the Pavement for the Lung Cancer Research Foundation’s Dallas Free to Breathe Walk Dallas, TX –Dallas residents …
Canada’s federal government unveiled this week the final part of its plans to ban the use and sale of asbestos in the country by the end of the year. The regulations, to come into effect on Dec. 30, also prohibit the manufacturing, import, trade and use …
Daiichi Sankyo Company, Limited announced that the first patient has been dosed in a first-in-human phase 1 study assessing the safety and tolerability of DS-1205, a highly selective investigational AXL inhibitor, in combination with gefitinib in patients …
Xconomy San Diego — Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO. The San Diego-based biotech, which is developing targeted cancer drugs for …
NANOBIOTIX: POSITIVE PHASE II/III RESULTS FOR NBTXR3 IN SOFT TISSUE SARCOMA PRESENTED AT ESMO Dr. Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at Institut Curie - Paris, presented first-in-class NBTXR3 positive Phase II/III …
“This project will hopefully save lives by helping people better understand the dangers of all tobacco products and encourage them to quit the habit,” Mr Hazzard said. The alarming figure comes from a 2005 World Health Organisation advisory note that …
With the message of love, unity and a mutual need to laugh at the little things, nearly a thousand people garbed in pink met at the 26th annual Power of Pink! Luncheon on Thursday. Kay Frances, the author of “The Funny Thing About Stress,” served as the …
Novartis announced Phase II preliminary results of the GEOMETRY mono-1 clinical trial of investigational MET inhibitor capmatinib (INC280) in 94 adult patients with advanced non-small cell lung cancer or NSCLC harboring MET exon-14 skipping mutations. The …
AEB4104 is a Novel Engineered Human Enzyme with Unique Specificity for Degrading Both Homocysteine and Homocystine AEB4104 Prevents Death, Stops Disease Progression, and Reverses Liver Pathology in a Disease Model of Homocystinuria AUSTIN, Texas, Oct. 19, …
Data presented at the European Society of Medical Oncology (ESMO) 2018 meeting in Munich, Germany by three clinical oncology research groups demonstrate the importance of a highly sensitive test for detection of clinically-relevant mutations present in …
Dr. Douglas Blayney from Stanford University to Join to Discuss Recently Announced Clinical Data NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of …
Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.
Track news across more than 5,000 sources by country or industry or search our real-time news index.
News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.
Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.
Have an event? Add it to our Events & Conferences Directory.
This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 09/22/2018
MODESTO, CALIFORNIA, UNITED STATES, October 19, 2018 /EINPresswire.com/ -- Academic Physician Life Care Planning, LLC provides Sanchez proof testimony for its defense and plaintiff life care plans that relates to the anticipated cost of …
Waite Enterprise CEO Daniel Waite working closely with Miles Clark to build out the health sector of Corporate Holdings. DALLAS, TX, USA, October 19, 2018 /EINPresswire.com/ -- Clinical Based Research is a successful clinical research …
ABINGTON, PENNSYLVANIA, UNITED STATES, October 19, 2018 /EINPresswire.com/ -- Donna L. Lauck is one of those people who is proud to say she became what she wanted to be as a child. From the time she could talk, Donna told everyone she wanted to …
NEW YORK, NEW YORK, USA, October 19, 2018 /EINPresswire.com/ -- The Arizona Mesothelioma Victims Center says, "We are urging a nuclear power, public utility, electric, water, or natural gas worker who has recently been diagnosed with …
TAMPA, Fla., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Nextech Systems, a leading provider of healthcare technology solutions for specialty physician practices, including Ophthalmology, will offer multiple educational opportunities in their booth #2262 at the …
TORONTO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE:PILL) (“Canntab” or the “Company”), a leader in the development of precision oral dose cannabis tablets and capsules, is pleased to announce that it has filed an application to …
FARMINGDALE, N.Y., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report its …
BARRIE, Ontario, Oct. 19, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (“MediPharm Labs” or the “Company”) (TSXV: LABS) continues to build momentum towards its goal of becoming a global leader in pharmaceutical-grade cannabis concentrates, by adding to …
Boston, MA, Oct. 19, 2018 (GLOBE NEWSWIRE) -- TIME Magazine named Angie Truesdale, CEO of Centering Healthcare Institute, to its first annual list of 50 most influential people in health care. Of the list, TIME editors write, "The American health …
WARSAW, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug …
Download logo The International Committee of the Red Cross (ICRC) has facilitated the release of 24 persons detained in relation to the conflict in South Sudan, including 16 detainees released on Friday. This week marks the first releases of prisoners …
Data Safety Monitoring Board met on October 15, 2018 for final analysis Interim and final results of the Phase 2b study to be presented on Monday, October 22, 2018 during an oral presentation at the European Society for Medical Oncology (ESMO) 2018 Annual …
AEB4104 is a Novel Engineered Human Enzyme with Unique Specificity for Degrading Both Homocysteine and Homocystine AEB4104 Prevents Death, Stops Disease Progression, and Reverses Liver Pathology in a Disease Model of Homocystinuria AUSTIN, Texas, Oct. 19, …
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in …
Wayne, PA, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for debilitating genetic diseases with no approved treatments, …
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi receives positive CHMP opinion for dengue vaccine Paris, France - October 19, 2018 - The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has …
VANCOUVER, British Columbia, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Integrated Cannabis”), is pleased to announce the signing of a Letter of Intent (the “LOI”) to acquire all of the issued and …
Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond Previously Announced Spine and Neuro License Agreement IRVINE, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- MRI …
Data Show Vectra Test Is Correlated with Treatment Response SALT LAKE CITY, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced new data from two studies of Vectra® that …
Study will incorporate genomic precision medicine ANAVEX®2-73-specific biomarkers NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing …
Welcome to EIN Newsdesk
Millions of professionals find us an indispensable source for
breaking news. Basic accounts are FREE.
Sources
We scan thousands of news sites, so you don't have to, saving
you time and money.
Topics
We are similar to Google News but focus on news tracking by country,
industry and topic, so you don't miss any important news
that affects your company, organization or interest.
Custom News
Any news page or search results can be turned into an email news alert
or live RSS feed. You can share relevant news on your website,
intranet, workgroup or mobile device.
News Alert Maker
It's a one-stop destination for all your alerts and feeds.
Manage your media monitoring in one secure location.
Relevant. Time-Saving. Free.
And so easy to use. Check out our short video and
check in with us to start right now.
Get Started
Join millions of professionals in business, industry, and government who
have relied on EIN News since 1995.
